Characterizing Anti-Müllerian Hormone (AMH) concentration and change over time in Holstein dairy cattle.

The objective of this study was to characterize circulating Anti-Müllerian Hormone (AMH) concentrations in a population of Holstein heifers and examine the impact that life events and stage of life have on those concentrations. Virgin, Holstein heifers (n = 105) 13 ± 0.8 months old were heat detected using tail-chalk, bred via artificial insemination and pregnancy checked 32+ days later. Serum samples for AMH were collected upon enrollment (heifer), at 5-20 days in milk (fresh) and at 45-60 days in milk (pre-breeding). Transrectal ultrasonography was performed upon enrollment (heifer) and at 45-60 days in milk (pre-breeding) to determine antral follicle count (AFC), cyclicity status, and uterine health. Heifers were blocked into thirds by AMH concentration: HIGH (>354 pg/mL; n = 34), MID (183-354 pg/mL; n = 35) and LOW (<183 pg/mL; n = 36), with distribution re-evaluated at subsequent samplings (fresh, pre-breeding). As heifers, age and conception risk to first service were not impacted by AMH (P > 0.05). Reason for leaving the herd, health incidences and calving difficulty were not impacted by AMH (P > 0.05). AFC and cyclicity had a positive impact on heifer AMH (P < 0.01). AFC and AMH in heifers were highly correlated (0.56, P < 0.001). AFC for heifers differed by AMH group with the HIGH group having the greatest AFC (8.76), followed by the MID (5.87), then the LOW (3.53) group (P < 0.0001). However, this association was not evident in the pre-breeding group (P > 0.05). From the heifer to the fresh sample, average AMH dropped from 313.15 pg/mL to 160.01 pg/mL (P < 0.0001). Average AMH at the pre-breeding sample was 183.23 pg/mL, which was lower than the heifer sample (P < 0.0001), but not different from the fresh sample (P > 0.05). AFC and AMH at the heifer sample had a positive impact on AMH at the fresh sample (P < 0.01) and pre-breeding AMH was positively impacted by both the fresh and heifer AMH concentration (P < 0.001). Most animals kept their AMH categorization through all three time points with more of the LOW AMH animals maintaining their categorization than the other groups. However, 32.1% of animals changed their AMH categorization from the heifer sample to the fresh sample, with 53.8% moving to a lower AMH categorization (corresponding to lower AMH) and 46.2% moving to a higher AMH categorization (corresponding to higher AMH). No differences were seen in circulating AMH based on health events however, differences in AMH concentration over time indicate a drop in circulating AMH post-calving. Circulating AMH concentration as a pre-breeding heifer is highly indicative of circulating AMH concentration as a first lactation animal and may be used to predict an adult animal's AMH concentration. However, it is necessary to compare AMH concentrations to herdmates as published AMH values vary widely from herd to herd. In addition, sampling time should be considered when determining AMH categorization of animals as circulating AMH concentration immediately post-calving may not be indicative of an animal's true AMH categorization.

Effect of maternal cells transferred with colostrum on cellular responses to pathogen antigens in neonatal calves.

OBJECTIVE: To assess the effect of maternal cells or cellular components on neonatal immune responses to intracellular pathogens in calves. ANIMALS: 15 Holstein calves. PROCEDURES: Calves were fed whole colostrum, frozen colostrum, or cell-free colostrum within 4 hours after birth. Leukocytes were obtained from calves before feeding colostrum and 1, 2, 7, 14, 21, and 28 days after ingestion. Proliferative responses against bovine viral diarrhea virus (BVDV) and mycobacterial purified protein derivatives were evaluated. Dams received a vaccine containing inactivated BVDV, but were not vaccinated against mycobacterial antigens. RESULTS: All calves had essentially no IgG in circulation at birth, but comparable and substantial concentrations by day 1. Calves that received whole colostrum had enhanced responses to BVDV antigen 1 and 2 days after ingestion of colostrum. In contrast, calves that received frozen colostrum or cell-free colostrum did not respond to BVDV. No differences were identified among the 3 groups in response to mycobacterial antigens. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated that transfer of live maternal cells from colostrum to neonatal calves enhanced responses to antigens against which the dams had previously responded (BVDV), but not to antigens to which the dams were naïve (mycobacterial purified protein derivatives). Results suggested that cell-mediated immune transfer to neonates can be enhanced by maternal vaccination.